OVERVIEW

2026 IOTOX Symposium: Delivering What Matters - Patient-Centered through IOTOX Translational Science is organized by The University of Texas MD Anderson Cancer Center and will be held from Apr 24 - 25, 2026 at MD Anderson - Sheikh Zayed Building, Houston, Texas, United States of America.

Description:
This symposium is designed to create a space where experts from different backgrounds can connect and learn from each other. The focus is on the latest research and clinical practices related to immunotherapy toxicities. Participants will hear from leaders in the field, explore new technologies, and dive into practical strategies for managing complex cases. The goal is to turn cutting-edge science into everyday solutions that improve care and outcomes for patients dealing with immune-related side effects.

Objectives:
At the conclusion of this activity, learners will be able to:

  • Develop treatment plans that follow current guidelines for managing immunotherapy toxicities.
  • Find and use national society recommendations to guide care decisions.
  • Apply IOTOX guidelines that have been reviewed and approved by both oncologists and internal medicine experts.
  • Evaluate complex patient cases and tailor treatment plans to meet individual needs.
  • Use IOTOX protocols across the care team to ensure coordinated and effective care.

KEY DATES

Event Start Date
24 Apr, 2026
Event Start Date
Event End Date
25 Apr, 2026
Event End Date
Credits

Accreditation
In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 9.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Texas MD Anderson Cancer Center designates this live activity will award 9.00 Nursing Contact Hour(s)Credit Designation

AMERICAN BOARD OF INTERNAL MEDICINE (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf.  In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 9.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 9 AMA PRA Category 1 Credits™
  • 9 MOC
  • 9 Contact Hours
  • TARGET AUDIENCE

    PhysicianPharmacistPhysician AssistantStudentsInternal MedicineLicensed Vocational Nurses (LVN)Trainees

    SPECIALITIES

    Internal Medicine

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationMD Anderson - Sheikh Zayed Building
    6565 MD Anderson Blvd

    RELATED CONFERENCES & LIVE WEBINARS

    Sep 24 - 26, 2026 | Dallas, Texas, USA

    State required course for Illinois ...
    33 CME/CE
    More actions
    US$2,295

    Sep 23 - 25, 2026 | Las Vegas, Nevada,...

    Primary Care
    15 Contact Hours
    ...
    More actions
    US$199

    Sep 24, 2026 | Dallas, Texas, USA

    State required course for Dist of Col ...
    10 CME/CE
    More actions
    US$995